Polaroid Therapeutics completes pre-clinical milestones in the development of superior antimicrobial technology for acute and chronic wounds

Its proprietary innovative polymer technology reduces bacterial bioburden without triggering antimicrobial resistance, one of the top global public health threatsThe Advanced Wound Dressing (AWD) market is valued at 4.5 billion USD and is witnessing increasing demand and technological advancementsThe company is looking to expand development and commercial collaborations with industry leadersView original content:https://www.prnewswire.co.uk/news-releases/polaroid-therapeutics-completes-pre-clinical-milestones-in-the-development-of-superior-antimicrobial-technology-for-acute-and-chronic-wounds-302059016.html

en | boerse | 67949492 |